Critical Cases - Thyrotoxic Periodic Paralysis

HPI

 

  • 30 yo healthy male p/w generalized fatigue, b/l UE and LE weakness and pain for several hours
  • Denies strenuous activity, change in diet, falls, trauma, midline back pain, bowel and or bladder incontinence
  • Hospitalized 3 months prior for unexplained hypokalemia (K <2.0) that resolved with IV repletion

 

PE

Vitals: BP 182/78 | Pulse 61 | Temp 97.7 °F (Oral) | Resp 22 | SpO2 100% 

 

  • Awake and alert, appears fatigued
  • Dry MM, cap refill greater than 3 seconds
  • 4/5 strength b/l UE
  • 3/5 strength b/l LE
  •  

    Sensation to light touch intact in bilateral upper and lower extremities

  • 2+ patellar reflexes bilaterally
  • Unable to ambulate due to weakness

Ddx for Generalized Weakness

 

  •  Hypokalemia/hyperkalemia vs rhabdomyolysis vs periodic paralysis vs spinal cord compression vs uillan Barre syndrome

 

Initial Diagnostics

 

  • Initial labs notable for K 1.9, Mg 1.5, and P 1.1
  •  

    Initial ECG (see below)

 

 

 

 

Management

 

  • Electrolytes repleted as follows…
    • 40 mEq oral K, 20 mEq IV K
    •  2 gm Mg over 2 hours
    •  

      2 tablets of Neutra-Phos

 

Case Progression

  

  • Ultimately diagnosed with hyperthyroidism, likely secondary to Graves’ disease
    • TSH <0.01
    • Ultrasound thyroid
      • Enlarged heterogeneous thyroid with diffusely increased vascularity
      • Thyroid nodule of the isthmus
    • Started on Methimazole and Propranolol

 

  • Presenting symptoms and electrolyte abnormalities attributed to thyrotoxic periodic paralysis

 

Thyrotoxic Periodic Paralysis (TPP)

 

  • Potentially life-threatening
  • Defined as the triad of
    • Muscle paralysis
    • Acute hypokalemia
    • Hyperthyroidism
  • Less than half of TPP patients exhibit clinical signs of hyperthyroidism
  • Rapid recognition and termination are mandatory to avoid potentially fatal complications of severe hypokalemia
    • Cardiac arrhythmias
    •  

      Respiratory failure

  • Management complicated by the thin line between refractory hypokalemia and rebound hyperkalemia
  • KCl supplementation is essential but often not enough to control TPP
  • IV propranolol has been reported to reverse weakness and hypokalemia in patients unresponsive to KCl administration

 

References

Bilha S, Mitu O, Teodoriu L, Haba C, Preda C. Thyrotoxic Periodic Paralysis-A Misleading Challenge in the Emergency Department. Diagnostics (Basel). 2020;10(5):316. Published 2020 May 18. doi:10.3390/diagnostics10050316

 

Lin SH, Huang CL. Mechanism of thyrotoxic periodic paralysis. J Am Soc Nephrol. 2012;23(6):985-988. doi:10.1681/ASN.2012010046